Merrimack Pharma (MACK) Announces Final Phase 3 NAPOLI-1 Study Results; Previous OS Advantage Maintained
Go back to Merrimack Pharma (MACK) Announces Final Phase 3 NAPOLI-1 Study Results; Previous OS Advantage MaintainedMERRIMACK PHARM (NASDAQ: MACK) | Delayed: 14.75 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $14.75 | 52 Week High | $9.63 | |||
Open | $14.75 | 52 Week Low | $4.39 | |||
Day High | $14.75 | P/E | N/A | |||
Day Low | $14.75 | EPS | $-1.24 | |||
Volume | 700 |
ShangPharma Corp. ADS (NYSE: SHP) | Delayed: 8.95 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $8.95 | 52 Week High | $26.30 | |||
Open | $8.95 | 52 Week Low | $26.03 | |||
Day High | $8.95 | P/E | N/A | |||
Day Low | $8.95 | EPS | $0.00 | |||
Volume | 1,942,335 |
Shire pic (NASDAQ: SHPG) | Delayed: 179.20 +101.90 (131.82%) | |||||
---|---|---|---|---|---|---|
Previous Close | $77.30 | 52 Week High | $219.52 | |||
Open | $77.29 | 52 Week Low | $147.60 | |||
Day High | $77.49 | P/E | N/A | |||
Day Low | $179.20 | EPS | $0.00 | |||
Volume | 302,425 |